Switzerland-Ireland Bilateral Trade Analysis 2023

Complete trade statistics: $8.14B total volume •Switzerland deficit: $2.48B

SwitzerlandIreland

$2.83B

Exports (2023)

IrelandSwitzerland

$5.31B

Imports (2023)

Trade Balance

$2.48B

Deficit for Switzerland

Total Trade

$8.14B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Switzerland and Ireland. Green line shows exports from Switzerland, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Switzerland-Ireland commercial relationship and competitive positioning in global markets.

SwitzerlandIreland Exports

$2.83B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
34.2% top product
1Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)
$967.95M
34.2% of exports
2Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$211.46M
7.5% of exports
3Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$195.62M
6.9% of exports
4Pacemakers: for stimulating heart muscles (excluding parts and accessories)
$152.85M
5.4% of exports
5Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$142.11M
5.0% of exports
6Heterocyclic compounds: containing an unfused thiazole ring (whether or not hydrogenated) in the structure
$104.49M
3.7% of exports
7Wrist-watches: electrically operated, with or without a stop-watch, (other than those of heading no. 9101) with mechanical display only
$83.40M
2.9% of exports
8Wrist-watches: whether or not incorporating a stop-watch facility, with automatic winding
$74.87M
2.6% of exports
9Medical, surgical instruments and appliances: catheters, cannulae and the like
$74.77M
2.6% of exports
10Heterocyclic compounds: n.e.c. in headings no. 2933
$51.14M
1.8% of exports

🎯 Strategic Export Focus

Switzerland's export portfolio to Ireland demonstrates strong diversification across multiple sectors, with heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) representing a key competitive advantage in this bilateral market.

IrelandSwitzerland Imports

$5.31B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
28.0% concentration
1Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale
$1.49B
28.0% of imports
2Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions
$1.41B
26.7% of imports
3Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$363.31M
6.8% of imports
4Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN)
$331.28M
6.2% of imports
5Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$314.48M
5.9% of imports
6Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$237.14M
4.5% of imports
7Medical, surgical instruments and appliances: catheters, cannulae and the like
$101.60M
1.9% of imports
8Units of automatic data processing machines: processing units other than those of item no. 8471.41 or 8471.49, whether or not containing in the same housing one or two of the following types of unit: storage units, input units or output units
$71.99M
1.4% of imports
9Heterocyclic compounds: n.e.c. in headings no. 2933
$55.41M
1.0% of imports
10Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg
$53.60M
1.0% of imports

📦 Import Strategy Analysis

Switzerland's import pattern from Ireland reveals strategic sourcingin blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

🏆

Market Leadership

Switzerland demonstrates competitive strength in exportingheterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) to Ireland, leveraging comparative advantages.

Export Leader in 20+ Categories
🔄

Trade Complementarity

The bilateral relationship showsmoderatecomplementarity, with each country specializing in different sectors.

Specialized Exchange
📈

Growth Potential

The $8.14B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Significant Partnership

Executive Summary: Switzerland-Ireland Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $8.14 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Switzerland maintains a deficit of $2.48 billion
  • Export Focus: Switzerland's primary exports include heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale, heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
  • Import Dependencies: Key imports from Ireland include blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale, blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions, medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthImbalanced

📈 Market Position: This bilateral trade relationship represents an important regional trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $8.14B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Switzerland leveraging its comparative advantages in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn).

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Switzerland's specialization in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn)complements Ireland's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $8.14B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyHigh
🔮

Trade Relationship Outlook

The $8.14B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

💰

Trade Volume Impact

The $8.14 billion bilateral trade volume represents a important trade relationshipfor both economies.

Economic Significance: Moderate
🏭

Industrial Integration

Trade flows in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) and blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
⚖️

Trade Balance Effects

Switzerland's trade deficit of $2.48 billion impacts its overall economic position in this bilateral relationship.

Balance Impact: Import Dependency

Strategic Future Outlook

🚀Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale present expansion opportunities.
Market Diversification
Beyond current focus on blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale, new product categories offer potential for trade expansion.

⚠️Risk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn) may affect future market positioning.

🎯Strategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Switzerland and Ireland represents a total trade volume of $8.14 billion in 2023. This partnership demonstrates an unfavorable trade balance for Switzerland, with imports exceeding exportsby $2.48 billion.

Export Strengths

Switzerland's exports to Ireland total $2.83 billion, with competitive advantages in heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) and clobazam (inn) and methyprylon (inn), representing $967.95M or34.2% of bilateral exports.

Import Dependencies

Imports from Ireland amount to $5.31 billion, highlighting economic interdependence in blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale, with Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale comprising28.0% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade deficit indicates Switzerland's strategic sourcing from Ireland. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Switzerland and Ireland in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023